Dan G. Duda, DMD, PhD
Dan G. Duda, DMD, PhD
Associate Professor of Tumor Biology, Massachusetts General Hospital and Harvard Medical School
Verified email at partners.org - Homepage
Title
Cited by
Cited by
Year
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett, Y Boucher, E Di Tomaso, DG Duda, LL Munn, RT Tong, ...
Nature medicine 10 (2), 145-147, 2004
22942004
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ...
Cancer cell 11 (1), 83-95, 2007
19062007
Angiogenesis in brain tumours
RK Jain, E Di Tomaso, DG Duda, JS Loeffler, AG Sorensen, TT Batchelor
Nature Reviews Neuroscience 8 (8), 610-622, 2007
13002007
Normalization of the vasculature for treatment of cancer and other diseases
S Goel, DG Duda, L Xu, LL Munn, Y Boucher, D Fukumura, RK Jain
Physiological reviews 91 (3), 1071-1121, 2011
12662011
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
RK Jain, DG Duda, JW Clark, JS Loeffler
Nature clinical practice Oncology 3 (1), 24-40, 2006
12572006
Engineering vascularized tissue
RK Jain, P Au, J Tam, DG Duda, D Fukumura
Nature biotechnology 23 (7), 821-823, 2005
7552005
Biomarkers of response and resistance to antiangiogenic therapy
RK Jain, DG Duda, CG Willett, DV Sahani, AX Zhu, JS Loeffler, ...
Nature reviews Clinical oncology 6 (6), 327-338, 2009
6012009
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Y Huang, J Yuan, E Righi, WS Kamoun, M Ancukiewicz, J Nezivar, ...
Proceedings of the National Academy of Sciences 109 (43), 17561-17566, 2012
5782012
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study
CG Willett, DG Duda, E Di Tomaso, Y Boucher, M Ancukiewicz, ...
Journal of Clinical Oncology 27 (18), 3020, 2009
5462009
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
M Stroh, JP Zimmer, DG Duda, TS Levchenko, KS Cohen, EB Brown, ...
Nature medicine 11 (6), 678-682, 2005
5232005
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
AX Zhu, DV Sahani, DG Duda, E Di Tomaso, M Ancukiewicz, ...
Journal of clinical oncology 27 (18), 3027, 2009
5182009
Phase II study of cediranib, an oral pan–vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
TT Batchelor, DG Duda, E di Tomaso, M Ancukiewicz, SR Plotkin, ...
Journal of Clinical Oncology 28 (17), 2817, 2010
4882010
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal …
CG Willett, Y Boucher, DG Duda, E Di Tomaso, LL Munn, RT Tong, ...
Journal of Clinical Oncology 23 (31), 8136-8139, 2005
4722005
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
D Fukumura, J Kloepper, Z Amoozgar, DG Duda, RK Jain
Nature reviews Clinical oncology 15 (5), 325, 2018
4692018
HCC and angiogenesis: possible targets and future directions
AX Zhu, DG Duda, DV Sahani, RK Jain
Nature reviews Clinical oncology 8 (5), 292, 2011
4402011
Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre‐clinical models
DAI Fukumura, DG Duda, LL Munn, RK Jain
Microcirculation 17 (3), 206-225, 2010
4342010
Malignant cells facilitate lung metastasis by bringing their own soil
DG Duda, AMMJ Duyverman, M Kohno, M Snuderl, EJA Steller, ...
Proceedings of the National Academy of Sciences 107 (50), 21677-21682, 2010
4332010
CXCL12 (SDF1α)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?
DG Duda, SV Kozin, ND Kirkpatrick, L Xu, D Fukumura, RK Jain
Clinical cancer research 17 (8), 2074-2080, 2011
4232011
Vascular normalization as an emerging strategy to enhance cancer immunotherapy
Y Huang, S Goel, DG Duda, D Fukumura, RK Jain
Cancer research 73 (10), 2943-2948, 2013
4102013
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis
D Fukumura, A Ushiyama, DG Duda, L Xu, J Tam, V Krishna, K Chatterjee, ...
Circulation research 93 (9), e88-e97, 2003
3922003
The system can't perform the operation now. Try again later.
Articles 1–20